Last Updated on Apr
28, 2006 8:15 pm
---- TODAY PICKS ----
Apr 28, 2006
Our system did not generate any high performer stock pick today.
Please visit here next trading day again
April profit is 283% with 100% accuracy
Please see the below signals for the next trading day
April
Symbol Entry Date Entry Price Exit Date Exit Price VOLUME Profit/Loss CLST 31-Mar-06 2.38 05-Apr-06 3.2 1089700 34.5% RDWR 03-Apr-06 15.6 05-Apr-06 15.74 3172900 0.9% ENT 03-Apr-06 12.49 05-Apr-06 15 3023300 20.1% JMAR 04-Apr-06 0.62 06-Apr-06 0.78 2113400 25.8% CBAY 11-Apr-06 0.25 13-Apr-06 0.29 1817300 20.8% AVM 11-Apr-06 29.40 13-Apr-06 31.7 1194700 7.8% NSOL 20-Apr-06 1.31 25-Apr-06 1.51 2454711 15.3% OTD 20-Apr-06 1.70 24-Apr-06 2.0 6956300 17.6% SCHK 24-Apr-06 39.19 26-Apr-06 41.51 801600 5.9% DOVP 27-Apr-06 8.13 HOLD 875147 -
TODAY STOCK MARKET
SIMULATION PERFORMANCE RESULTS HAVE INHERENT LIMITATIONS, THESE PERFORMANCE
TABLES AND RESULTS ARE BASED ON BACKTESTING OF CERTAIN TRADING STRATEGIES.
DO NOT REPRESENT TRADING IN ACTUAL ACCOUNTS
You may have more losses or profits in your account comparing to other
member accounts due to many factors, including but not limited to: you and
other people may trade stock picks in different orders, orders not get
filled or partially get filled, selective trading some specific stock picks
instead of all stock picks, paying different commission fees required by
different brokerages, stock positions entered and exited at different price
other than our suggested price due to market orders, order execution
delayed, various human decisions or technical failures.
You
may lose all of your money when investing and trading in the stock markets!
The data contained in the reports within this site is provided for
informational purposes only. It should not be viewed as a solicitation for
the referenced system or vendor. While the information and statistics given
are believed to be complete and accurate, we cannot guarantee their
completeness or accuracy. As past performance does not guarantee future
results, these results may have no bearing on, and may not be indicative of,
any individual returns realized through participation in this or any other
investment. No part of this document should be considered apart from the
Disclosure Statements contained herein.
|
|
||||||||||
|
||||||||||
|
DOV Pharmaceutical Inc. (DOVP) 433 Hackensack Avenue Hackensack, NJ 07601 Phone: 201-968-0980 Fax: 201-968-0986 Web Site: http://www.dovpharm.com
DOV Pharmaceutical, Inc. engages in the discovery, acquisition, development, and commercialization of drug candidates for central nervous system and cardiovascular disorders. The company’s lead product Bicifadine, which is used for treatment of chronic low back pain, is in phase-3 clinical trials. Its other products, which are in various stages of development, include Indiplon, for treatment of insomnia; DOV 21,947 and DOV 216,303 for depression; DOV 102,677 for alcohol abuse and alcoholism; and DOV Diltiazem for the treatment of angina and hypertension. DOV Pharmaceutical has agreements with Neurocrine Biosciences, Inc.; Pfizer, Inc.; and Merck & Co., Inc. The company was co-founded by Robert Cancro, Bernard Beer, and Arnold S. Lippa in 1995. DOV Pharmaceutical is based in Hackensack, New Jersey..
|
||||||||||
|
|
